Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP1 | P29466 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | PREP | P48147 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | F2 | P00734 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | CES1 | P23141 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6947156 | 0.90 | CASP1 (0.53) | CASP1ALDH1A1PREPL3MBTL1 | |
| SCHEMBL9506098 | 0.85 | L3MBTL1 (0.53) | CASP1ALDH1A1MAPTPREPSMN1; SMN2 | |
| SCHEMBL28516086 | 0.84 | L3MBTL1 (0.55) | CASP1ALDH1A1MAPTPREPSMN1; SMN2 | |
| SCHEMBL1934716 | 0.80 | ALDH1A1 (0.50) | CASP1ALDH1A1L3MBTL1PKM | |
| Trifluoroacetic Acid SCHEMBL4700417 | 0.76 | PREP (0.40) | CASP1ALDH1A1PREPSMN1; SMN2L3MBTL1 | |
| Trifluoroacetic Acid SCHEMBL4700336 | 0.76 | PREP (0.40) | CASP1ALDH1A1PREPSMN1; SMN2L3MBTL1 | |
| SCHEMBL21281736 | 0.76 | CASP1 (0.53) | CASP1LMNAALDH1A1SMN1; SMN2L3MBTL1 | |
| Trifluoroacetic Acid SCHEMBL27579421 | 0.75 | TSHR (0.62) | ALDH1A1L3MBTL1CES1 | |
| SCHEMBL6628631 | 0.74 | CASP1 (0.41) | CASP1L3MBTL1 | |
| SCHEMBL7414944 | 0.74 | CASP1 (1.00) | CASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1444202-A1 | NOVEL METALLOPROTEINASE INHIBITORS | AstraZeneca AB (SE) | 2004-08-11 | — | — | EP | disclosed |
| WO-2003040098-A1 | NOVEL METALLOPROTEINASE INHIBITORS | ASTRAZENECA AB (SE) | 2003-05-15 | — | — | WO | disclosed |